Patents
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
04/1997
04/23/1997CN1034663C Method for preparing hemoregulatory peptides
04/22/1997US5623049 Flexible antisense agents comprising oligonuceotides having the (deoxy)ribose backbone replaced by an oligopeptide; protease- and nuclease-resistant; viricides; attached to carriers able to penetratate in cells
04/22/1997US5622934 Treating diabetes mellitus
04/22/1997US5622931 Human tissue factor related DNA segments, polypeptides and antibodies
04/22/1997US5622828 Contacting mixture of nucleic acids with secretory phospholipase a2, partitioning increased affinity nucleic acids, amplifying
04/22/1997CA2031265C Methods of detecting collagen degradation in vivo
04/17/1997WO1997013783A1 An acceptor polypeptide for an n-acetylgalactosaminyltransferase
04/17/1997WO1997013493A1 Use of bradykinin antagonists for stimulating or inducing hair growth and/or arresting hair loss
04/17/1997WO1997013410A1 Hybrid molecules containing amidated polypeptide binding ligands
04/17/1997WO1996028468A3 Amphiphilic peptide and analogs thereof
04/16/1997EP0768318A2 Peptide having collagen contraction inhibiting activity
04/16/1997EP0767835A1 Denervated muscle kinase (dmk), a receptor of the tyrosine kinase super family
04/16/1997EP0767801A1 Endothelin antagonists ii
04/16/1997CN1147819A New opioid peptide analogs with mixed MU agonist/delta antagonist properties
04/16/1997CN1034577C Producing process for peptides having bradykinin-antagonistic action
04/15/1997US5621076 Poultry Mycoplasma antigens and recombinant vectors containing the gene as well as diagnostics and vaccines utilizing the same
04/15/1997US5620959 Bombesin antagonists
04/15/1997US5620958 Bradykinin antagonists
04/15/1997US5620957 Hemoregulatory peptides
04/15/1997US5620956 Inhibiting differentiation of cytotoxic t-lymphocyte precursor to mature cell specific for foreign antigen
04/15/1997US5620955 Synthetic peptide derivatives; inhibit growth of small cell lung cancer or pancreatic cells
04/15/1997US5620954 Peptide compositions and uses therefor
04/15/1997US5620688 Methods of inhibiting the activation of Factor XIII
04/15/1997US5620675 Medical diagnosis
04/10/1997WO1997012988A1 Coiled-coil heterodimer methods and compositions for the detection and purification of expressed proteins
04/10/1997WO1997012850A2 Bifunctional, sulphide-containing sulphonamide-chelating agents of xsny type for radioactive isotopes
04/10/1997WO1997012636A2 Bifunctional sulphide-containing sulphonamide s2ny-type chelate-forming agents for radioisotopes
04/10/1997WO1997012624A1 Novel peptides
04/10/1997WO1996026961A3 Peptidyl compounds comprising an itim motif which regulate hematopoietic function and their use
04/10/1997CA2233272A1 Novel peptides
04/10/1997CA2232620A1 Bifunctional sulfide-containing sulfonamide-chelating agents such as xsny for radioactive isotopes
04/10/1997CA2232315A1 Bifunctional sulfide-containing sulfonamide-chelating agents such as s2 ny for radioactive isotopes
04/10/1997CA2187485A1 Peptide and collagen contraction inhibitor
04/09/1997EP0766737A2 Polypeptides with interleukin 8 receptor 1 (il8r1) binding domains
04/09/1997EP0766736A1 Human monoclonal antibodies specific to cell cycle independent glioma surface antigen
04/09/1997EP0548217B1 Process for the preparation of c-terminally amidated peptides
04/09/1997CN1147261A Factor Xa inhibitors
04/09/1997CN1034506C Method for preparing medicinal composition contg. glycopeptide derivs.
04/08/1997USRE35492 Wound treatment employing biologically active ion channel forming peptides and proteins
04/08/1997US5618914 Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same
04/08/1997US5618791 Reduced side effects
04/08/1997US5618787 Cyclic peptide antifungal agents
04/08/1997US5618698 Growing host cells transformed or transfected with specified isolated dna sequence, isolating erythropoietin product
04/08/1997US5618528 Biologically compatible linear block copolymers of polyalkylene oxide and peptide units
04/03/1997WO1997012060A1 ARF-p19, A NOVEL REGULATOR OF THE MAMMALIAN CELL CYCLE
04/03/1997WO1997012048A1 Recombinant viruses incorporating a protease cleavable protein
04/03/1997WO1997011964A1 Truncated glial cell line-derived neurotrophic factor
04/03/1997WO1997011963A1 ANTI-GALα(1,3)GAL ANTIBODY BINDING PEPTIDES
04/03/1997WO1997011962A1 Cyclic peptide analogs of somatostatin
04/03/1997WO1997011959A1 Biologically active mhc peptides having a repeated amino acid sequence motif
04/03/1997WO1997011715A1 Mimicking peptides in cancer therapy
04/03/1997WO1996038473A3 Antimicrobial cationic peptides
04/03/1997CA2232669A1 Recombinant viruses incorporating a protease cleavable protein
04/02/1997EP0765478A1 Positive and positive/negative cell selection mediated by peptide release
04/02/1997EP0765341A1 Template directed cyclization
04/02/1997EP0765165A1 Constrained peptides
04/02/1997CN1146771A Piptide fragments and analogs derived from pBAN 1-33 NHz for controlling moths
04/02/1997CN1146726A Block copolymers
04/02/1997CN1146458A Cardiovascular active polypeptide and its synthesis and medical use
04/01/1997US5616685 snRNP-A antigen and fragments thereof
04/01/1997US5616684 Cyclic hexapeptide containing aspartic acid and derivatives, 2-thienylglycine, leucine, and tryptophan; endothelin receptor antagonist
04/01/1997US5616595 Concentration, solubilizing, diafiltration in a closed recirculation system
04/01/1997US5616556 Method of treating rheumatoid arthritis and osteoarthrosis using tetrahydro WS9326A
04/01/1997US5616327 M-protein peptides of influenza virus as antiviral agents
04/01/1997US5616322 Sperm antigen corresponding to a sperm zona binding protein autoantigenic epitope
04/01/1997CA1339043C Nonapeptide and decapetide analogs of lhrh useful as lhrh antagonists
03/1997
03/27/1997WO1997011092A1 Cyclosporin phosphate derivatives and medicinal composition
03/27/1997WO1997010853A2 N2s2-type bi-functional nicotinamide chelating agents for radioactive isotopes
03/27/1997WO1997010851A2 Nucleic acid delivery vehicle
03/27/1997WO1997010837A1 Tumor rejection antigens presented by hla-b44 molecules, and uses thereof
03/27/1997WO1997010836A1 Peptides and peptidomimetics inhibiting the oncogenic action of p21 ras
03/27/1997WO1997010796A2 MANIPULATION AND DETECTION OF PROTEIN PHOSPHATASE 2C - PP2Cα - EXPRESSION IN TUMOR CELLS FOR CANCER THERAPY, PREVENTION AND DETECTION
03/27/1997WO1997010711A1 Methods and compositions for suppressing an immune response using major histocompatibility complex (mhc) class ii peptides
03/27/1997DE19536785A1 Bifunktionelle sulfidhaltige Sulfonamid-Chelatbildner vom Typ S¶2¶NY für radioaktive Isotope Bifunctional sulfide-containing sulfonamide-type chelating agent S¶2¶NY for radioactive isotopes
03/27/1997DE19536783A1 Bifunktionelle Nicotinamid-Chelatbildner vom Typ N¶2¶S¶2¶ für radioaktive Isotope Bifunctional nicotinamide-type chelating agent N¶2¶S¶2¶ for radioactive isotopes
03/27/1997DE19536780A1 Bifunktionelle sulfidhaltige Sulfonamid-Chelatbildner vom Typ XSNY für radioaktive Isotope Bifunctional sulfide-containing sulfonamide-type chelating agent XSNY for radioactive isotopes
03/27/1997CA2232750A1 Peptides and peptidomimetics inhibiting the oncogenic action of p21 ras
03/27/1997CA2232340A1 Bifunctional nicotinamide-chelating agents such as n2s2 for radioactive isotopes
03/27/1997CA2231172A1 Nucleic acid delivery vehicle
03/27/1997CA2230119A1 Methods and compositions for suppressing an immune response using major histocompatibility complex (mhc) class ii peptides
03/27/1997CA2227306A1 Manipulation and detection of protein phosphatase 2c - pp2c.alpha. - expression in tumor cells for cancer therapy, prevention and detection
03/26/1997EP0764203A1 Methods for selectively stimulating proliferation of t cells
03/26/1997EP0764171A1 Ligands for induction of antigen specific apoptosis in t cells
03/26/1997EP0642531B1 Monomer and dimer peptides, utilization as cytoprotector agents and preparation method
03/26/1997EP0482080B1 Small cyclic platelet aggregation inhibitors
03/26/1997CN1146208A Peptides as therapeutic agents for treatment of auto-immune diseases
03/25/1997US5614499 Anticoagulants; treatment or prophylaxis of thrombosis
03/25/1997US5614497 Treatment of hypertension, cardiovascular disease and renal disease
03/25/1997US5614494 Peptides for heparin and low molecular weight heparin anticoagulation reversal
03/25/1997US5614366 HTLV-I peptide antigens and kit
03/25/1997CA1339027C Synthetic peptides, antibodies directed against them, and the use thereof
03/25/1997CA1339014C Antibodies to a4 amyloid peptide
03/20/1997WO1997010507A1 Molecules that home to a selected organ or tissue in vivo and methods of identifying same
03/20/1997WO1997010264A1 Cyclic hexapeptide compounds
03/20/1997WO1997010263A1 Actinomycin d analogues
03/20/1997WO1997010261A1 Peptide derivatives
03/20/1997WO1997009995A1 Method for reducing the severity of gastro-intestinal damage
03/20/1997WO1997000892A3 Depigmenting activity of agouti signal protein and peptides thereof
03/20/1997CA2232140A1 Cyclic hexapeptide compound
03/20/1997CA2231174A1 Peptide derivatives